Monday, medical device maker TranS1, Inc. (TSON) reported a wider loss in fourth quarter compared to previous year quarter. Revenues for the quarter, however, were increased.
The Wilmington, North Carolina-based company's net loss for the fourth quarter was $4.53 million or $0.22 per share, wider from a net loss of $2.24 million or $0.14 per share in the same quarter of last year.
On an adjusted basis, net loss for the quarter was $4.15 million or $0.20 per share, compared to a net loss of $1.37 million or $0.07 per share in the year ago quarter. Revenues for the quarter were $7.4 million, up 48% from $5.0 million in the prior-years quarter. Gross margin for the quarter was 84.7%, an increase from 83.3% in the fourth quarter of last year.
Analysts polled by Thomson Reuters expected the company to report a net loss of $0.25 per share on revenues of $6.37 million. Analysts' estimates typically exclude special items.
For the full year period, the company's net loss was $17.0 million or $0.84 per share, wider from $8.6 million or $1.46 per share in the year-ago period.
Revenues for the full year period were $25.3 million, up from $16.5 million in the preceding year period.
TSON closed Monday's regular trading at $5.96, down $0.20 or 3.25% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.